Jin Medical International (ZJYL) Equity Average (2024 - 2025)
Jin Medical International's (ZJYL) quarterly Equity Average came in at $15.4 million in Q3 2025, down 43.86% year-on-year from $27.4 million in Q3 2024, and down 45.45% quarter-over-quarter from $28.2 million in Q1 2025.
Jin Medical International (ZJYL) Equity Average (2024 - 2025) Analysis & Trends
Jin Medical International has disclosed Equity Average across 2 years of filings, most recently posting $15.4 million for Q3 2025.
- Equity Average for Q3 2025 came in at $15.4 million, down 43.86% year-over-year; the trailing twelve-month figure through Sep 2025 was $15.4 million (down 43.86% YoY), and the FY2025 annual result was $15.8 million, down 40.01% from the prior year.
- Equity Average came in at $15.4 million for Q3 2025 at Jin Medical International, down from $28.2 million in the prior quarter.
- In the past five years, Equity Average ranged from a high of $28.2 million in Q1 2025 to a low of $15.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 17.71 Bn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | 20.42 Bn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 11.00 Bn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 6.41 Bn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 3.08 Bn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 5.01 Bn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | 8.30 Bn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 4.10 Bn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 6.07 Bn |
| 10 | Jin Medical International | - | - | - | 15.36 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 15.36 Mn |
| Mar 31, 2025 | 28.15 Mn |
| Sep 30, 2024 | 27.35 Mn |
| Mar 31, 2024 | 25.07 Mn |